Karen Prange, Director at AtriCure, Inc. (ATRC), sold 12,200 shares at $38.12 ($465K) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Open-market sale of $465k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.12 | 6,100 | $233K | 50.0% |
| 2 | $38.12 | 6,100 | $233K | 50.0% |
| Total | $38.12 avg | 12,200 | $465K | 100% |
| Filing → |
| VRAY | SELL | 2023-07-21 | $9K | — | Filing → |
| ATRC | SELL | 2023-06-12 | $34K | — | Filing → |
| VRAY | BUY | 2022-05-12 | $100K | — | Filing → |